Income Statement Medacta Group SA

Equities

MOVE

CH0468525222

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange Other stock markets 11:31:52 2026-01-16 am EST			5-day change	1st Jan Change
164.80 ^CHF	+0.37%		-1.90%	+5.37%

Dec. 10	OssDsign Names CEO to Join January 2026	MT
25-10-10	Berenberg Raises Medacta Price Target Amid Strong Earnings Momentum	MT

b5d18b1269e8285f152b3bd3e71733.3eA-ucu2zlpXpVnyR2oco2AcdUjU2uxF75X6eeP6iQk.iqVr24-Cnzk9kBOAKA51yQRENx3mv70PgPC7Ebur8zurjGqIhvyZICLfGA

Published financial data: MEDACTA GROUP SA

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	302M	363M	437M	511M	591M
Total Revenues	302M	363M	437M	511M	591M
Cost of Goods Sold, Total	88.24M	102M	132M	163M	191M
Gross Profit	214M	261M	305M	348M	399M
Selling General & Admin Expenses, Total	155M	183M	220M	252M	286M
R&D Expenses	6.83M	10.91M	15.08M	18.77M	19.68M
Other Operating Expenses	-697K	-1.14M	505K	90K	672K
Other Operating Expenses, Total	161M	193M	236M	271M	307M
Operating Income	52.84M	67.98M	69.46M	76.51M	92.94M
Interest Expense, Total	-3.04M	-3.44M	-3.66M	-6.83M	-7.51M
Interest And Investment Income	144K	332K	348K	103K	221K
Net Interest Expenses	-2.9M	-3.11M	-3.32M	-6.73M	-7.29M
Currency Exchange Gains (Loss)	-7.66M	1.03M	-2.98M	-10.46M	7.53M
Other Non Operating Income (Expenses)	1.05M	-1.25M	-381K	1.47M	-3.31M
EBT, Excl. Unusual Items	43.33M	64.66M	62.78M	60.79M	89.87M
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-1.14M	-901K	-	-	-
Asset Writedown	-	-397K	-517K	-791K	-572K
Legal Settlements	840K	-7.91M	-6.85M	-524K	-398K
Other Unusual Items	-3.1M	-	-627K	-753K	-1.14M
EBT, Incl. Unusual Items	39.93M	55.45M	54.79M	58.73M	87.77M
Income Tax Expense	2.84M	3.93M	8.54M	11.36M	14.88M
Earnings From Continuing Operations	37.09M	51.52M	46.25M	47.36M	72.89M
Net Income to Company	37.09M	51.52M	46.25M	47.36M	72.89M
Net Income - (IS)	37.09M	51.52M	46.25M	47.36M	72.89M
Net Income to Common Incl Extra Items	37.09M	51.52M	46.25M	47.36M	72.89M
Net Income to Common Excl. Extra Items	37.09M	51.52M	46.25M	47.36M	72.89M
Per Share Items
Net EPS - Basic	1.85	2.58	2.32	2.37	3.66
Basic EPS - Continuing Operations	1.85	2.58	2.32	2.37	3.66
Basic Weighted Average Shares Outstanding	20M	20M	19.98M	19.95M	19.92M
Net EPS - Diluted	1.85	2.58	2.31	2.37	3.65
Diluted EPS - Continuing Operations	1.85	2.58	2.31	2.37	3.65
Diluted Weighted Average Shares Outstanding	20M	20M	20M	19.99M	19.96M
Normalized Basic EPS	1.35	2.02	1.96	1.9	2.82
Normalized Diluted EPS	1.35	2.02	1.96	1.9	2.81
Dividend Per Share	-	0.52	0.55	0.59	0.74
Payout Ratio	-	-	22.53	23.34	15.36
Supplemental Items
EBITDA	81.95M	98.72M	107M	120M	142M
EBITA	56.15M	71.12M	72.68M	79.72M	96.2M
EBIT	52.84M	67.98M	69.46M	76.51M	92.94M
EBITDAR	82.08M	98.89M	107M	120M	142M
Effective Tax Rate - (Ratio)	7.11	7.09	15.59	19.35	16.96
Total Current Taxes	7.18M	8.5M	7.7M	7.38M	8.69M
Total Deferred Taxes	-4.34M	-4.57M	844K	3.98M	6.19M
Normalized Net Income	27.08M	40.41M	39.24M	38M	56.17M
Interest on Long-Term Debt	345K	324K	496K	1.2M	1.6M
Non-Cash Pension Expense	-1.35M	-1.43M	-1.71M	-2.82M	-2.24M
Supplemental Operating Expense Items
Selling and Marketing Expenses	110M	133M	160M	187M	211M
General and Administrative Expenses	45.21M	50.94M	60.62M	65.8M	75.6M
Research And Development Expense From Footnotes	6.83M	11.31M	16.22M	20.32M	21.39M
Net Rental Expense, Total	122K	173K	170K	317K	200K
Imputed Operating Lease Interest Expense	19.59K	33.35K	32.39K	92.09K	53.7K
Imputed Operating Lease Depreciation	102K	140K	138K	225K	146K
Stock-Based Comp., Other (Total)	-	468K	1.15M	2.31M	3.82M
Total Stock-Based Compensation	-	468K	1.15M	2.31M	3.82M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	48.07M	20.4M	32.26M	20.79M	31.59M
Total Cash And Short Term Investments	48.07M	20.4M	32.26M	20.79M	31.59M
Accounts Receivable, Total	45.78M	59.44M	77.96M	94.65M	108M
Other Receivables	5.42M	7.86M	7.21M	6.85M	10.68M
Total Receivables	51.2M	67.29M	85.16M	101M	119M
Inventory	114M	136M	160M	214M	234M
Prepaid Expenses	2.95M	2.78M	3.18M	3.79M	4.79M
Other Current Assets, Total	1.3M	1.47M	2.75M	8.46M	5.74M
Total Current Assets	218M	228M	284M	348M	395M
Gross Property Plant And Equipment	298M	360M	441M	539M	636M
Accumulated Depreciation	-145M	-180M	-223M	-271M	-318M
Net Property Plant And Equipment	153M	180M	218M	267M	318M
Goodwill	59K	59K	59K	59K	59K
Other Intangibles, Total	16.84M	16.05M	14.35M	13.5M	12.91M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	21.59M	29.03M	31.66M	27.94M	24.68M
Deferred Charges Long-Term	31.89M	35.87M	35.78M	37.86M	40.65M
Other Long-Term Assets, Total	488K	479K	481K	712K	995K
Total Assets	442M	489M	584M	696M	792M
Liabilities
Accounts Payable, Total	16.48M	25.95M	28.48M	38.85M	35.39M
Accrued Expenses, Total	22.34M	27.96M	32.13M	39.81M	41.58M
Current Portion of Long-Term Debt	66.34M	64.49M	7.09M	46.92M	50.82M
Current Portion of Leases	5.4M	5.71M	6.36M	8.61M	10.33M
Current Income Taxes Payable	23.2M	6.84M	9.42M	7.44M	9.83M
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	11.06M	5.6M	5.58M	7.78M	9.6M
Total Current Liabilities	145M	137M	89.06M	149M	158M
Long-Term Debt	65.04M	49.55M	138M	116M	143M
Long-Term Leases	13.64M	15.47M	21.37M	32.14M	39.36M
Pension & Other Post Retirement Benefits	13.02M	12.14M	8.86M	12.58M	17.57M
Deferred Tax Liability Non Current	36.27M	39.84M	44.62M	48.7M	49.02M
Other Non Current Liabilities	4.43M	9.31M	8.33M	6.91M	5.65M
Total Liabilities	277M	263M	310M	366M	413M
Common Stock, Total	1.78M	1.78M	1.78M	1.78M	1.78M
Additional Paid In Capital	21.23M	21.23M	16.02M	10.49M	4.89M
Retained Earnings	139M	192M	236M	282M	346M
Treasury Stock	-	-	-	-8.07M	-9.48M
Comprehensive Income and Other	2.31M	11.03M	21.14M	43.53M	36.4M
Total Common Equity	165M	226M	275M	330M	380M
Total Equity	165M	226M	275M	330M	380M
Total Liabilities And Equity	442M	489M	584M	696M	792M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	20M	19.99M	19.96M	19.93M	19.92M
ECS Total Common Shares Outstanding	20M	19.99M	19.96M	19.93M	19.92M
Book Value / Share	8.24	11.33	13.76	16.56	19.06
Tangible Book Value	148M	210M	260M	316M	367M
Tangible Book Value Per Share	7.39	10.52	13.04	15.88	18.41
Total Debt	150M	135M	172M	204M	244M
Net Debt	102M	115M	140M	183M	212M
Debt Equivalent of Unfunded Proj. Benefit Obligation	10.11M	8.93M	5.46M	7.33M	12.69M
Debt Equivalent Oper. Leases	976K	1.38M	1.36M	2.54M	1.6M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	15.21M	19.13M	26.7M	36.67M	48.11M
Inventories - Work In Process, Total	11.16M	14.48M	18.05M	24.04M	22.16M
Inventories - Finished Goods, Total	87.81M	102M	116M	153M	164M
Inventories - Others	-	-	-	-	-
Land - (BS)	7.42M	7.73M	12.93M	15.43M	17.51M
Buildings, Total	36.3M	44.12M	48.23M	52.08M	60.18M
Machinery, Total	219M	270M	333M	402M	471M
Full Time Employees	1.18K	1.34K	1.54K	1.66K	1.91K
Part Time Employees	-	-	-	68	-
Accumulated Allowance for Doubtful Accounts (Supple)	988K	2.55M	2.45M	4.27M	6.74M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	37.09M	51.52M	46.25M	47.36M	72.89M
Depreciation & Amortization - CF	30.49M	32.14M	39.9M	46.63M	53.78M
Amortization of Goodwill and Intangible Assets - (CF)	3.31M	3.13M	3.23M	3.21M	3.26M
Depreciation & Amortization, Total	33.8M	35.27M	43.13M	49.84M	57.04M
Amortization of Deferred Charges, Total - (CF)	3.2M	4.76M	7.87M	7.81M	8.19M
(Gain) Loss From Sale Of Asset	1.14M	901K	-22K	-140K	-78K
Asset Writedown & Restructuring Costs	12K	397K	517K	791K	572K
Stock-Based Compensation (CF)	-	468K	1.15M	2.31M	3.82M
Other Operating Activities, Total	888K	-12.78M	13.82M	13.25M	11.02M
Change In Accounts Receivable	718K	-13.94M	-17.74M	-19.18M	-15.56M
Change In Inventories	-13.49M	-16.79M	-20.78M	-44.09M	-28.38M
Change In Accounts Payable	-1.39M	8.52M	1.43M	8.47M	-3.04M
Change in Other Net Operating Assets	-2.39M	-4.27M	-2.11M	8.7M	672K
Cash from Operations	59.59M	54.06M	73.51M	75.13M	107M
Capital Expenditure	-27.28M	-46.49M	-58.4M	-69.66M	-89.26M
Sale of Property, Plant, and Equipment	3.22M	2.57M	6.38M	7.08M	7.69M
Cash Acquisitions	-	-	-220K	-	-
Sale (Purchase) of Real Estate properties	-	-	-4.75M	-1.58M	-
Sale (Purchase) of Intangible assets	-10.09M	-8.13M	-8.1M	-10.98M	-15.43M
Investment in Marketable and Equity Securities, Total	-32K	10K	-8K	-5.46M	-1.87M
Cash from Investing	-34.19M	-52.04M	-65.11M	-80.61M	-98.87M
Long-Term Debt Issued, Total	4.34M	846K	59.16M	30.48M	71.21M
Total Debt Issued	4.34M	846K	59.16M	30.48M	71.21M
Long-Term Debt Repaid, Total	-10.37M	-30.82M	-42.39M	-25.64M	-50.9M
Total Debt Repaid	-10.37M	-30.82M	-42.39M	-25.64M	-50.9M
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-	-1.24M	-2.92M	-3.91M	-4.79M
Common Dividends Paid	-	-	-10.42M	-11.05M	-11.19M
Common & Preferred Stock Dividends Paid	-	-	-10.42M	-11.05M	-11.19M
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	-6.03M	-31.21M	3.44M	-10.13M	4.32M
Foreign Exchange Rate Adjustments	1.45M	1.53M	15K	4.14M	-1.8M
Net Change in Cash	20.83M	-27.66M	11.86M	-11.47M	10.8M
Supplemental Items
Cash Interest Paid	1.88M	1.7M	2.3M	5.78M	5.75M
Cash Income Tax Paid (Refund)	8.5M	25.43M	8.34M	8.78M	10.24M
Levered Free Cash Flow	27.16M	-18.48M	-7.76M	-35.12M	-15.85M
Unlevered Free Cash Flow	29.06M	-16.33M	-5.47M	-30.85M	-11.16M
Change In Net Working Capital	3.59M	44.71M	34.52M	58M	33.6M
Net Debt Issued / Repaid	-6.03M	-29.97M	16.77M	4.84M	20.31M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	7.73	9.13	8.09	7.47	7.81
Return on Total Capital	11.17	12.56	10.74	9.75	10.04
Return On Equity %	25.76	26.35	18.46	15.66	20.54
Return on Common Equity	25.76	26.35	18.46	15.66	20.54
Margin Analysis
Gross Profit Margin %	70.83	71.94	69.83	68.1	67.64
SG&A Margin	51.33	50.53	50.38	49.43	48.45
EBITDA Margin %	27.09	27.18	24.47	23.42	24.08
EBITA Margin %	18.56	19.58	16.63	15.61	16.29
EBIT Margin %	17.47	18.72	15.89	14.98	15.74
Income From Continuing Operations Margin %	12.26	14.19	10.58	9.27	12.34
Net Income Margin %	12.26	14.19	10.58	9.27	12.34
Net Avail. For Common Margin %	12.26	14.19	10.58	9.27	12.34
Normalized Net Income Margin	8.95	11.13	8.98	7.44	9.51
Levered Free Cash Flow Margin	8.98	-5.09	-1.78	-6.88	-2.68
Unlevered Free Cash Flow Margin	9.61	-4.5	-1.25	-6.04	-1.89
Asset Turnover
Asset Turnover	0.71	0.78	0.81	0.8	0.79
Fixed Assets Turnover	1.95	2.18	2.2	2.1	2.02
Receivables Turnover (Average Receivables)	6.45	6.9	6.36	5.92	5.82
Inventory Turnover (Average Inventory)	0.82	0.81	0.89	0.87	0.85
Short Term Liquidity
Current Ratio	1.5	1.67	3.18	2.33	2.51
Quick Ratio	0.69	0.64	1.32	0.82	0.95
Operating Cash Flow to Current Liabilities	0.41	0.4	0.83	0.5	0.68
Days Sales Outstanding (Average Receivables)	56.77	52.88	57.36	61.67	62.85
Days Outstanding Inventory (Average Inventory)	447.61	448.33	410.2	419.17	429.24
Average Days Payable Outstanding	62.32	62.55	63.65	56.74	64.2
Cash Conversion Cycle (Average Days)	442.06	438.66	403.92	424.1	427.89
Long Term Solvency
Total Debt/Equity	91.32	59.73	62.78	61.74	64.23
Total Debt / Total Capital	47.73	37.39	38.57	38.17	39.11
LT Debt/Equity	47.77	28.72	57.88	44.91	48.13
Long-Term Debt / Total Capital	24.97	17.98	35.56	27.77	29.3
Total Liabilities / Total Assets	62.73	53.73	53.01	52.57	52.07
EBIT / Interest Expense	17.36	19.75	18.96	11.2	12.37
EBITDA / Interest Expense	28.46	30	30.74	18.5	19.96
(EBITDA - Capex) / Interest Expense	19.5	16.49	14.79	8.3	8.08
Total Debt / EBITDA	1.74	1.31	1.53	1.61	1.63
Net Debt / EBITDA	1.18	1.11	1.24	1.45	1.42
Total Debt / (EBITDA - Capex)	2.53	2.38	3.18	3.59	4.02
Net Debt / (EBITDA - Capex)	1.72	2.02	2.59	3.23	3.5
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-2.62	20.04	20.38	16.85	15.62
Gross Profit, 1 Yr. Growth %	-4.22	21.93	16.85	13.95	14.83
EBITDA, 1 Yr. Growth %	23.24	20.45	9.35	11.86	18.84
EBITA, 1 Yr. Growth %	29.7	26.66	3.52	9.68	20.67
EBIT, 1 Yr. Growth %	31.79	28.65	3.54	10.16	21.47
Earnings From Cont. Operations, 1 Yr. Growth %	212.77	38.9	-10.23	2.41	53.89
Net Income, 1 Yr. Growth %	212.77	38.9	-10.23	2.41	53.89
Normalized Net Income, 1 Yr. Growth %	27.02	49.21	-1.52	-3.17	47.83
Diluted EPS Before Extra, 1 Yr. Growth %	212.77	39.27	-10.34	2.6	54.01
Accounts Receivable, 1 Yr. Growth %	-4.72	29.82	31.16	21.41	14.28
Inventory, 1 Yr. Growth %	12.35	19.18	17.79	33.45	9.58
Net Property, Plant and Equip., 1 Yr. Growth %	-2.6	17.2	21.56	22.35	18.76
Total Assets, 1 Yr. Growth %	7.12	10.71	19.46	19.06	13.84
Tangible Book Value, 1 Yr. Growth %	40.88	42.27	23.75	21.61	15.87
Common Equity, 1 Yr. Growth %	33.66	37.45	21.32	20.16	15.04
Cash From Operations, 1 Yr. Growth %	39.77	-9.28	35.98	2.2	42.61
Capital Expenditures, 1 Yr. Growth %	-34.21	70.39	25.63	19.26	28.15
Levered Free Cash Flow, 1 Yr. Growth %	-366.81	-168.05	-59.24	352.4	-54.86
Unlevered Free Cash Flow, 1 Yr. Growth %	-459.68	-156.2	-67.6	463.62	-63.84
Dividend Per Share, 1 Yr. Growth %	-	-	5.89	8.14	24.46
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.34	8.12	20.21	18.6	16.24
Gross Profit, 2 Yr. CAGR %	2.49	8.07	19.36	15.39	14.39
EBITDA, 2 Yr. CAGR %	-1.64	21.84	14.24	10.6	15.3
EBITA, 2 Yr. CAGR %	-6.68	28.17	13.78	6.56	15.04
EBIT, 2 Yr. CAGR %	-7.45	30.21	14.65	6.8	15.67
Earnings From Cont. Operations, 2 Yr. CAGR %	-9.96	108.43	11.66	-4.12	25.54
Net Income, 2 Yr. CAGR %	-9.96	108.43	11.66	-4.12	25.54
Normalized Net Income, 2 Yr. CAGR %	-13.73	37.67	20.37	-2.35	19.64
Diluted EPS Before Extra, 2 Yr. CAGR %	-9.96	108.45	11.74	-4.09	25.7
Accounts Receivable, 2 Yr. CAGR %	1.9	11.22	30.49	26.19	17.79
Inventory, 2 Yr. CAGR %	13.12	15.72	18.48	25.38	20.93
Net Property, Plant and Equip., 2 Yr. CAGR %	7.42	6.85	19.36	21.95	20.55
Total Assets, 2 Yr. CAGR %	9.95	8.9	15	19.26	16.42
Tangible Book Value, 2 Yr. CAGR %	45.4	41.57	32.69	22.68	18.7
Common Equity, 2 Yr. CAGR %	35.99	35.54	29.13	20.74	17.57
Cash From Operations, 2 Yr. CAGR %	-5.27	12.61	11.07	17.88	20.73
Capital Expenditures, 2 Yr. CAGR %	-22.26	5.88	46.31	22.4	23.63
Levered Free Cash Flow, 2 Yr. CAGR %	87.91	34.75	-46.53	35.8	42.9
Unlevered Free Cash Flow, 2 Yr. CAGR %	113.45	42.17	-56.6	35.14	42.77
Dividend Per Share, 2 Yr. CAGR %	-	-	-	7.01	16.01
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.33	10.03	12.06	19.08	17.6
Gross Profit, 3 Yr. CAGR %	5.47	8.6	10.92	17.53	15.2
EBITDA, 3 Yr. CAGR %	4.55	5.23	17.17	13.44	13.28
EBITA, 3 Yr. CAGR %	2.02	3.32	18.85	12.39	11.07
EBIT, 3 Yr. CAGR %	1.58	3.29	20.1	13.13	11.48
Earnings From Cont. Operations, 3 Yr. CAGR %	3.46	4.04	57.4	8.49	12.26
Net Income, 3 Yr. CAGR %	3.46	4.04	57.4	8.49	12.26
Normalized Net Income, 3 Yr. CAGR %	-3.42	3.56	22.55	11.95	12.13
Diluted EPS Before Extra, 3 Yr. CAGR %	-86.96	4.04	57.35	8.61	12.31
Accounts Receivable, 3 Yr. CAGR %	7.46	10.47	17.51	27.39	22.09
Inventory, 3 Yr. CAGR %	16.34	15.11	16.4	23.28	19.87
Net Property, Plant and Equip., 3 Yr. CAGR %	14.74	10.59	11.54	20.35	20.88
Total Assets, 3 Yr. CAGR %	13.81	10.2	12.31	16.34	17.42
Tangible Book Value, 3 Yr. CAGR %	20.79	44.35	35.36	28.89	20.36
Common Equity, 3 Yr. CAGR %	17.45	36.47	30.62	26.07	18.81
Cash From Operations, 3 Yr. CAGR %	4.93	-6.63	19.91	8.03	25.61
Capital Expenditures, 3 Yr. CAGR %	-3.46	0.98	12.09	36.67	24.29
Levered Free Cash Flow, 3 Yr. CAGR %	13.57	33.94	-8.63	8.95	-5.93
Unlevered Free Cash Flow, 3 Yr. CAGR %	14.04	36.8	-12.17	2.02	-12.91
Dividend Per Share, 3 Yr. CAGR %	-	-	-	-	12.54
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	10.64	12.31	13.38	13.71
Gross Profit, 5 Yr. CAGR %	-	9.69	10.82	11.27	12.29
EBITDA, 5 Yr. CAGR %	-	7.9	8.33	7.15	16.42
EBITA, 5 Yr. CAGR %	-	6.78	6.57	4.34	17.32
EBIT, 5 Yr. CAGR %	-	6.36	6.62	4.4	18.31
Earnings From Cont. Operations, 5 Yr. CAGR %	-	5.61	6.66	0.69	43.79
Net Income, 5 Yr. CAGR %	-	5.61	6.66	0.69	43.79
Normalized Net Income, 5 Yr. CAGR %	-	5.68	5.47	0.87	21.38
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-69.53	-69.23	0.71	43.83
Accounts Receivable, 5 Yr. CAGR %	-	10.5	16.14	16.51	17.62
Inventory, 5 Yr. CAGR %	-	15.1	17.2	19.11	18.19
Net Property, Plant and Equip., 5 Yr. CAGR %	-	12.25	16.57	15	15.06
Total Assets, 5 Yr. CAGR %	-	12.65	14.28	13.74	13.94
Tangible Book Value, 5 Yr. CAGR %	-	8.13	25.42	35.25	28.44
Common Equity, 5 Yr. CAGR %	-	9.04	21.99	29.95	25.24
Cash From Operations, 5 Yr. CAGR %	-	-0.81	7.34	2.5	20.24
Capital Expenditures, 5 Yr. CAGR %	-	16.98	14.01	9.06	16.57
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-15.98	35.49	9.27
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-22.51	37.06	6.67